Boyan Vesselinov Litchev - 01 Feb 2022 Form 4 Insider Report for Indaptus Therapeutics, Inc. (INDP)

Role
Chief Medical Officer
Signature
/s/ Boyan Litchev
Issuer symbol
INDP
Transactions as of
01 Feb 2022
Net transactions value
$0
Form type
4
Filing time
02 Feb 2022, 18:08:51 UTC
Previous filing
19 Dec 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INDP Stock Option (right to buy) Award $0 +90,000 $0.000000 90,000 01 Feb 2022 Common Stock 90,000 $4.97 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests and becomes exercisable as to one-third of the total shares on February 1, 2023 and thereafter the remaining shares vest and become exercisable in equal monthly installments over the following 24 months.